Breast

Papers
(The TQCC of Breast is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
P473: Percutaneous Ultrasound-Guided Cryoablation for the Treatment of Breast Cancer in Non-Surgical Patients2885
P149: Management of B3 breast lesions: clinical implications in light of the 2024 EUSOMA guidelines276
P305: The SLIM Approach: Introducing a novelway for the orientation of cavity shaves during breast conserving surgery in breast cancer patients205
P243: Partnership Between Breast Oncology Surgical Services and Hyperbaric Oxygen Therapy Unit Reduces Complications And Improves Outcomes188
P229: Impact of neoadjuvant chemotherapy on early relapses of luminal stage II breast cancer121
P332: Oncological Safety and Patient Satisfaction of Immediate Lipofilling in Breast-Conserving Surgery: A Systematic Reviewand Subgroup Meta-Analysis Comparing Outcomes with No Lipofilling104
P287: The Clinical efficacy of the ICG Fluorescence injection technique with blue dye for sentinel lymph node biopsy using dual injection technique in early breast cancer patients87
P279: Evaluation of Pathologic Complete Response (pCR) as a Surrogate for Event-Free Survival in neoadjuvant Human Epidermal Growth Factor Receptor 2–Positive (HER2+) Early Breast Cancer (eBC)87
P309: Four Grounds for Choosing Bilateral Free DIEP Flap Breast Reconstruction in Breast Cancer with Large and Ptotic Breasts: a retrospective case-control study83
P037 EGFR overexpression is related to immunohistochemical biomarkers in breast cancer68
PO118 RESULTS OF ANTI-HER 2 THERAPIES AFTER BRAIN METASTASES ON THE PROGNOSIS IN BREAST CANCER PATIENTS62
Using Radio-Occult Lesion Localization (Roll) Techniques To Identify The Clipped Node In Targeted Axillary Dissections (Tad)55
SA 1.1 Surgery of patients with early breast cancer: Quo vadis?52
P098 Adjuvant radiotherapy after radical surgery and immediate breast reconstruction52
P203 Comparing the combine flap fixation and Harmonic scalpel technique with the Harmonic scalpel alone in reducing seroma formation after mastectomy in breast cancer patient: A pilot study for a RCT52
No association between breast pain and breast cancer51
SA 9.1 Optimal neoadjuvant and adjuvant therapy for patients with early triple negative breast cancer50
P184 Unsatisfactory cosmetic results after oncoplastic breast-conserving surgery46
PO120 CAN A BREAST CANCER REGISTER MEASURE ADHERENCE TO NATIONAL ADVANCED BREAST CANCER (ABC) TREATMENT GUIDELINES IN CLINICAL PRACTICE?45
P152 The impact of the TailorX and RxPonder studies and the use of Oncotype Dx in clinical practice: A single Breast Cancer Center experience42
PO136 IMPACT OF ISOLATED SOLITARY BREAST CANCER LIVER METASTASIS SURGICAL RESECTION ON COMMON PATIENT HEALTH STATUS AND ABILITY TO PROCEED CHEMOTHERAPY40
Enhancing clinical decision support with genomic tools in breast cancer: A Scottish perspective39
A SYSTEMATIC REVIEW OF SAFETY AND IMPACT ON QUALITY OF LIFE WITH USE OF VAGINAL OESTROGENS DURING ENDOCRINE THERAPY FOR HORMONE RECEPTOR POSITIVE BREAST CANCER37
Individualising radiation therapy decisions in breast cancer patients based on tumour infiltrating lymphocytes and genomic biomarkers36
Editorial Board36
The continuing conundrum in oligometastatic breast carcinoma: A real-world data36
P280 How often do breast cancer patients seek traditional Chinese medicine in North China?36
Adenosquamous proliferation in radial sclerosing lesions: Histologic spectrum and key features in systematic review of 247 lesions36
Novel models based on machine learning to predict the prognosis of metaplastic breast cancer35
Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study34
Response to comment on: “Global guidelines for breast cancer screening: A systematic review”34
Corrigendum to “Current pattern of care in radiation therapy for DCIS in Australia - where are we heading?” [The Breast 82(2025) 104482]31
Corrigendum to “Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]31
Metastases of primary mixed no-special type and lobular breast cancer display an exclusive lobular histology30
Immediate breast reconstruction on overall and breast cancer-specific survival: A propensity score matched analysis29
Editorial Board29
Impact of stereotactic body radiation therapy on systemic therapeutic line change in oligometastatic breast cancer29
Postoperative complications of hypofractionated and conventional fractionated radiation therapy in patients with implant-based breast reconstruction: A systematic review and meta-analysis28
Efficacy and safety of oncoplastic breast-conserving surgery versus conventional breast-conserving surgery: An updated meta-analysis27
Sarcopenia in patients with metastatic breast cancer: A systematic review and meta-analysis27
Effect of palbociclib plus endocrine therapy on time to chemotherapy across subgroups of patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cance26
Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment target26
Baseline systemic inflammatory indices predict late radiation-induced fibrosis and toxicity in patients with early breast cancer25
Relationship between homologous recombination deficiency and clinical features of breast cancer based on genomic scar score25
Unveiling the future of breast cancer therapy: Cutting-edge antibody-drug conjugate strategies and clinical outcomes25
Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: The NOBROLA phase 2 study25
Increasing incidence of breast cancer in young women over time24
Optimising post-operative radiation therapy after oncoplastic and reconstructive procedures24
P026: Prediction of response to anti-HER2 therapy using multigene assay24
P335: Indocyanine green angiography for preventing postoperative mastectomy complications in immediate breast reconstruction. Protocol study23
P390: Extreme Oncoplastic Breast Conservation surgery: Indications and techniques23
P047: Clinicopathologic features and survival outcomes of metaplastic breast carcinoma patients: 20-year outcome results from an academic medical center in the United States23
P316: Clinical Management and Oncological Outcomes of Pure Pleomorphic and Florid Lobular Carcinoma in Situ of the Breast: Results fromthe MultiLCIS/OPBC International Multicentric Study23
P280: Identifying Predictive Factors of Lymph Node Involvement in Stage I and II Luminal Breast Cancers to Optimize Neoadjuvant Chemotherapy Indication23
P002: Genomic And Transcriptomic Profiling of Primary Tumors From Patients with HR+, HER2-, Node-positive, High-risk Early Breast Cancer (EBC) in the monarchE Trial22
P061: Tumor-infiltrating lymphocytes and tertiary lymphoid structures are associated with a higher upstaging risk of ductal carcinoma in situ in breast biopsies22
P040: Characterisation of Tropomyosin 3, a novel hypoxia induced gene, in Triple Negative Breast Cancer22
P018: Extended adjuvant (adj) neratinib in HER2+/HR+ early breast cancer (eBC) in clinical routine – interim analysis of the multinational, prospective, non-interventional study (NIS) ELEANOR (n = 30022
Reply to the letter: What can paintings teach us?21
P114: Evaluation of Sentinel Lymph Node by Sonography21
A patient-led survey on information and communication needs of patients with metastatic breast cancer in Ireland and Northern Ireland (CTRIAL-IE 23–05)21
P028: Confronting Barriers in HER2-Positive Metastatic Breast Cancer: Insights from a Phase II Trial of Inetetamab, Pyrotinib, and Chemotherapy21
Cropsi study: Efficacy and safety of cryotherapy and cryocompression in the prevention of chemotherapy-induced peripheral neuropathy in patients with breast and gynecological cancer–A prospective, ran21
Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases21
P439: ELEGANT: Elacestrant vs Standard ET in Women and Men With Node-positive, ER+, HER2- Early Breast Cancer (eBC) With High Risk of Recurrence – A Global, Multicenter, Randomized, Openlabel Phase 3 20
Early breast cancer in women aged 35 years or younger: A large national multicenter French population-based case control-matched analysis20
Author Index20
P430: Design of a single-institution prospective observational study to evaluate the efficacy and tolerability of four-drug antiemetic therapy for anthracycline-based chemotherapy for early breast can20
P423: Breast cancer survivors and patients’ perspectives on supportive cancer care at the Peace and Love Hospitals in Ghana20
P005 Impact of oral bacterial counts on febrile neutropenia during breast cancer chemotherapy20
P242 Use of Acellular Pericardial Biological Mesh for Prepectoral and Dual Plane Prosthetic Breast Reconstruction Following Conservative Mastectomies19
P017 Abemaciclib + endocrine therapy (ET) for HR+, HER2-, node-positive, high-risk EBC: results from a pre-planned monarchE overall survival (OS) interim analysis (IA), including 4-year efficacy outco19
PO75 A GLOBAL SURVEY OF YOUNG ADULTS LIVING WITH ALL STAGES OF BREAST CANCER WITH PARTICULAR INTEREST IN THOSE WITH METASTATIC BREAST CANCER, THEIR CO-SURVIVORS, AND THE HEALTHCARE PROVIDERS THAT CARE19
The long-term psychosocial consequences of screen-detected ductal carcinoma in situ and invasive breast cancer19
P097 Hypofractionated radiotherapy after neoadjuvant chemotherapy in Breast Cancer: Safety, feasibility, and early outcomes18
P264 The Comparison Outcome of Implant-based Breast Reconstruction with ADM, Non-ADM and TiLOOP Reconstruction in Breast Cancer Patients: A Case Series18
P175 Characteristics and Survival Outcomes of Breast Cancer Patients Discussed at Molecular Tumor Board of European Institute of Oncology18
Therapeutic mammaplasty does not increase false positive findings on surveillance mammography and ultrasound18
P279 A patient survey evaluating COVID-19-induced changes in follow-up of patients with EBC: opportunities for enhanced evidence-based practice?18
P125 Neoadjuvant pembrolizumab + chemotherapy vs placebo + chemotherapy followed by adjuvant pembrolizumab vs placebo for early TNBC: surgical outcomes from the phase 3 KEYNOTE-522 study17
SA 2.4 Assessing clinical utility and clinical validity of biomarkers in clinical trials17
THE IMPACT OF BODY MASS INDEX ON THERAPEUTIC EFFICACY OF CDK4/6 INHIBITORS IN ADVANCED OR RECURRENT BREAST CANCER PATIENTS17
PR137 CLINICALLY NODE NEGATIVE T4B BREAST CANCER IS A POOR INDICATION OF AXILLARY CLEARANCE: A SINGLE CENTRE EXPERIENCE17
REAL-WORLD EFFECTIVENESS AND SAFETY OF SACITUZUMAB GOVITECAN IN METASTATIC TRIPLE-NEGATIVE BREAST CANCER: A SINGLE-CENTRE COHORT WITH EXPLORATORY HER2-LOW SUBGROUP ANALYSIS17
Author Index17
Treatment of oligometastatic breast cancer: The role of patient selection16
Oncoplastic and reconstructive surgery in SENONETWORK Italian breast centers: lights and shadows16
Adjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysis16
Cost-effectiveness of inavolisib plus palbociclib-fulvestrant versus palbociclib plus fulvestrant as first-line treatment in HR+/HER2-advanced breast cancer16
PO148 A RANDOMIZED, CONTROLLED, PARALLEL-GROUP, TRIALON THE LONG-TERM EFFECTS OF MELATONIN ON FATIGUE ASSOCIATED WITH BREAST CANCER AND ITS ADJUVANT TREATMENTS16
Optimizing axillary lymph node management in early-stage HR+/HER2- breast cancer: Practical strategies for enhanced detection rates16
Response to the letter “Targeted digital intervention boosts endocrine therapy adherence in breast cancer patients with low health literacy”16
Cost-effectiveness of sacituzumab govitecan versus chemotherapy in advanced or metastatic triple-negative breast cancer16
Pleomorphic and florid lobular carcinoma in situ of the Breast: A systematic review of current evidence and knowledge gaps16
Response to "Critical appraisal of a machine learning model for predicting internal mammary lymph node metastasis in breast cancer"16
Preoperative reference values for breast cancer patients using the BREAST-Q16
Editorial Board16
Updated efficacy and safety of HLX02 versus reference trastuzumab in metastatic HER2-positive breast cancer: A randomized phase III equivalence trial16
P441: Breaking Barriers: Addressing Delayed Breast Cancer Diagnosis in Rural India through Cultural Sensitivity and Gender-Specific Care16
P432: Exploring the Role of Precision Medicine in Adjuvant Systemic Therapy for Early-stage Breast Cancer: A Prospective Cohort Study16
P041: Distinguishing Second Ipsilateral Locoregional Breast Cancer as True Recurrence or New Primary: A Comparison of Clinicopathological Classification and Molecular Clonality Analysis15
P160: The effectiveness of trastuzumab emtansine (TDM1) in metastatic breast cancer based on the duration of response to adjuvant HER2-targeted therapy15
P242: Global disparities in breast cancer treatment – an international survey15
P111: Cost-effectiveness of a breast cancer screening program in Switzerland15
P181: Acute and Late Toxicity after Hypofractionated Radiotherapy in Breast Cancer Patients Received Neoadjuvant Chemotherapy-Experience of our Department15
P186: Post-mastectomy radiotherapy negatively impacts short-term patient-reported outcomes in patients with and without immediate reconstruction – a retrospective cohort study15
P075: The Benefits of comprehensive NGS Panels using Liquid Biopsy in Breast Cancer15
P029: The contribution of the double blockade “Pertuzumab – Trastuzumab” in neo-adjuvant situation in localized Her2 positive Breast Cancers (Algerian experience)15
P284: Navigating Physical and Emotional Challenges After Mastectomy Without Reconstructive Surgery: A Study in Rural India15
P427: Exploring Treatment Adherence and Unmet Needs of Older Breast Cancer Patients in Nigeria14
IMPACT OF SYMPTOMATIC VERSUS ASYMPTOMATIC RELAPSE DETECTION ON POST-RELAPSE OUTCOMES IN EARLY-STAGE BREAST CANCER: A RETROSPECTIVE COHORT STUDY14
P343: Surgical management of positive margins after breast conservative surgery: 5-years monoistitutional records with 5-years follow-up14
Impact of adjuvant trastuzumab therapy and its discontinuation on cardiac function and mortality in patients with early-stage breast cancer: An analysis based on the Japanese Receipt Claim Database14
A nested case-control study on radiation dose-response for cardiac events in breast cancer patients in Germany14
P336: Sentinel Lymph Node Biopsy: Retrospective Analysis of Prognostic and Predictive Factors to Assess the Omission of Axillary Surgery14
Welcome14
EVALUATION OF CT83 EXPRESSION IN INVASIVE BREAST CANCER AND ITS CORRELATION WITH PDL1 EXPRESSION13
P187 Comparison of long term oncologic outcome of sentinel lymph node mapping methods, dye-only versus dye and radioisotope in breast cancer following neoadjuvant chemotherapy13
P065 High satisfaction of women in Slovenian breast cancer screening program DORA: results of an anonymous survey13
SA 2.3 Multi-omic machine learning prediction of treatment response13
Is circulating tumor cell count-driven cost-effective for first-line therapy choice in HR+/HER2- metastatic breast cancer in the United States?13
BARRIERS TO EARLY BREAST CANCER DIAGNOSIS IN RURAL INDIA: THE IMPACT OF GENDER PREFERENCE IN HEALTHCARE13
P161 The updated PREDICT breast cancer prognostication in 91, 182 patients using Korean Breast Cancer Registry Data13
ENDPOINTS IN BREAST CANCER TRIALS- WHAT TRULY MATTERS?13
P168 OncotypeDX RS new TAILORx cut-offs: omitting Chemotherapy in more patients aged >50 years with Early Breast Cancer13
BP52 DEVELOPMENT OF AN INFORMATION FILM FOR FRIENDS AND FAMILY OF PATIENTS WITH MBC “THEY JUST DON’T KNOW WHAT TO SAY OR DO”13
P105 Internal mammary chain irradiation in breast cancer patients: Which patterns of practice between controversial benefit and challenging dosimetry?13
Prognostic value of tumor-infiltrating lymphocytes (TILs) in Luminal breast cancer: A novel computational method for assessing TILs abundance and spatial distribution patterns12
P293 Classification of abnormal findings on dedicated breast PET for prediction of malignancy12
PO104 COMPARING EFFICACY AND TOXICITY IN HR+/HER2- METASTATIC BREAST CANCER PATIENTS TREATED WITH RIBOCICLIB OR PALBOCICLIB IN COMBINATION WITH ENDOCRINE THERAPY: RESULTS FROM A SINGLE CENTER IN MEXIC12
The impact of breast density notification on psychosocial outcomes in racial and ethnic minorities: A systematic review12
Trends in axillary surgery and clinical outcomes among breast cancer patients with sentinel node metastasis12
P189 Impact assessment of sentinel lymph node core needle biopsy guided by ultrasound for node-positive breast cancer patients12
P281 The effect of Chinese culture on family planning of Childbearing age women with breast cancer in North China12
P095 Ultra-hypofractionated adjuvant radiotherapy in very elderly ratients with early breast cancer12
Rates of reoperation after breast conserving cancer surgery in Western Australia before and after publication of the SSO-ASTRO margins guideline12
P117 Axillary residual disease after neoadjuvant treatment according to disease burden in the sentinel lymph node biopsy12
Does the 21-gene recurrence score have clinical utility in HR+/HER2+ breast cancer?12
Macrophage density is an adverse prognosticator for ipsilateral recurrence in ductal carcinoma in situ12
Emerging technologies for monitoring breast cancer response to neoadjuvant chemotherapy: a systematic scoping review11
Mammographic features at primary breast cancer diagnosis in relation to recurrence-free survival11
Switching to T-DM1 remains justified in patients with HER2-negative residual invasive breast cancer after neoadjuvant therapy11
Sentinel lymph node detection in early-stage breast cancer - Are technetium-99m-nanocolloid and superparamagnetic iron oxide diagnostically equivalent procedures? A propensity score matched real world11
Interactive multidisciplinary pilot workshop to improve medical student perception of and interest in breast surgical oncology11
Cognitive function is well preserved in a cohort of breast cancer survivors: Roles of cognitive reserve, resilience, and general health11
Additional intraoperative subpectoral plane block vs conventional pain control: A comparison of shoulder movement in patients with mastectomy11
EBCC-15 manifesto: Removing age-related barriers to improve equity in breast cancer care11
Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast cancer with increased r11
Impact of trastuzumab deruxtecan (T-DXd) and brain stereotactic radiosurgery on intracranial control and radionecrosis risk in HER2-positive or -low breast cancer brain metastases11
Locoregional recurrence in studies of primary systemic therapy in early invasive breast cancer11
P356: New Method for Nipple-Areolar Complex Reconstruction with FixNip - Nipple Reconstruction Implant (FixNip NRI™): A Preliminary Study10
BRIEF LITERATURE REVIEW OF NATIVE HAWAIIAN/PACIFIC ISLANDER REPRESENTATION IN ADVANCED STAGE BREAST CANCER10
P133 Immunohistochemical expression of estrogen receptors after neoadjuvant chemotherapy in breast cancer10
P085 Target axillary disecction in cN2 breast cancer patients after neoadjuvant chemotherapy. Preliminary results10
P240: Mapping cancer care trajectories: Treatment and service lived experiences of women with breast cancer10
P032: Brown adipocytes are more capable than ASC in promoting breast cancer invasiveness through cell fusion10
P346: Pre-operative MRI vs. no MRI in patients with ductal carcinoma in situ treated at two oncology centers in Lima, Peru (2016–2023): A real-world data analysis10
P299: A Systematic Cavity-Saving Technique for Reducing Margin Positivity in Breast-Conserving Surgery: A Cost-Effective Alternative to Frozen Section Biopsy (CSRP Study)10
ANALYSIS OF THE FREQUENCY AND ASSOCIATED FACTORS OF SKIN TOXICITY IN PATIENTS RECEIVING RIBOCICLIB-BASED THERAPY FOR METASTATIC BREAST CANCER10
Endorsements and Auspices10
Poster Session10
#MAKEMECOUNT: ADDRESSING THE NEED FOR COMPLETE AND HARMONIZED CANCER DATA IN CANADA10
Integration of translational research in phase III trials: A systematic review of breast cancer studies in a 5-year period10
P134: Eligibility for bilateral prophylactic mastectomy: an expert opinion study in the Netherlands10
P226: Real world evidence of neoadjuvant chemotherapy without anthracyclines in triple-negative breast cancer among Mexican patients10
Denosumab versus zoledronic acid in metastatic breast cancer: A retrospective observational analysis of 24-dose regimens on analgesia and skeletal-related event prevention10
KNOWLEDGE OF LYMPHOEDEMA CAUSES AND TREATMENT OPTIONS AMONG BULGARIAN PATIENTS – SNAPSHOT ANALYSIS10
SA 5.2 Risk assessment in ER positive disease: Who should receive CDK 4–6 inhibitors?10
BP48 WHAT IS A LIFE WITH MBC WORTH? THE CANCER CURRENCY CAMPAIGN: DEMANDING EQUITABLE TREATMENT FOR THOSE LIVING WITH METASTATIC BREAST CANCER10
Skin perfusion and oxygen saturation after mastectomy and radiation therapy in breast cancer patients10
P306: Comparison of oncological outcomes of Breast Reconstruction, Breast-Conserving, and Mastectomy Surgery in Breast Cancer Patients Undergoing Neoadjuvant Treatment: A Propensity Scorematched Analy10
P374: Comparison of Radioguided Occult Lesion Localization (ROLL) and Magnetic Marker Techniques for Preoperative Localization of Non-Palpable Breast Lesions in Breast-Conserving Surgery10
P043 Characteristics and clinical outcomes of patients with HER2-low breast cancer9
The Design And Development Of an Individualised Training Program For Metastatic Breast Cancer (MBC) Nursing Incorporating Remote And Onsite Learning Experiences During A Pandemic9
Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life9
Chemotherapy in older patients with early breast cancer9
BP132 LOCAL HERO: A PHASE II STUDY OF LOCAL THERAPY ONLY (STEREOTACTIC RADIOSURGERY AND/OR SURGERY) FOR TREATMENT OF UP TO 5 BRAIN METASTASES FROM HER2+ BREAST CANCER. (TROG STUDY 16.02)9
P283 Overall survival of patients treated for breast cancer: about 124 cases9
The role of vacuum assisted excision in diagnosis of papillary lesions without atypia9
Association of clinicopathologic variables and patient preference with the choice of surgical treatment for early-stage breast cancer: A registry-based study9
P162 Contralateral Breast Cancer in BRCA 1 vs 2 Mutation Carriers9
P211 Surgical treatment for elderly patients with ductal carcinoma in situ. Is it still a safety and valid option?9
IN25 WHEN SHOULD THE PRIMARY TUMOR BE TREATED IN ABC?9
Management of HR+/HER2+ lobular breast cancer and trends do not mirror better outcomes9
Knowledge in Motion: A decade reviewed, a future defined – The ABC Global Alliance 2015–2025 Decade Report and 2025–2035 Global Charter9
P215 Absent post-treatment changes in negative sentinel lymph nodes and regional recurrence in initially node positive breast cancer patients9
IN24 AI SUPPORTING PATIENT-CENTRIC HEALTHCARE LEARNING9
P208 Contrast-enhanced ultrasound using intradermal microbubble sulfur hexafluoride for identification of sentinel lymph nodes during breast cancer surgery: a clinical trial9
P003 ROSE trial: A prospective non-interventional study to assess the quality of life (QoL) of premenopausal patients with early breast cancer receiving triptorelin as ovarian function suppression9
P270 Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?9
PR125 EARLY RELAPSE OF HER2 POSITIVE BREAST CANCER9
PO143 MODELING AN ANNOUNCEMENT PATHWAY FOR PATIENTS ENTERING METASTATIC DISEASE CLINICAL ISSUES: SUPPORTIVE AND PALLIATIVE CARE9
Identifying premenopausal patients with early-stage hormone receptor–positive breast cancer at minimal risk of distant recurrence by breast cancer index9
P016 Patient Characteristics, Treatment and Long-term Outcomes from a Real-World Population of Early Breast Cancer Patients at High risk of Recurrence in Scotland9
PO65 PSYCHOLOGICAL AND RELIGIOUS COPING STRATEGIES IN MOROCCAN WOMEN RECENTLY DIAGNOSED WITH LOCALLY ADVANCED BREAST CANCER: BASELINE FINDINGS FROM COHORT STUDY9
Efficacy of antiandrogens in androgen receptor-positive triple-negative metastatic breast cancer: Real-life data9
Does mammographic density predict survival in women with invasive breast cancer? The need to account for potential confounding from cancer stage and overdiagnosis9
P265 Cryoablation in Breast Cancer Care - an analysis from a Single Multi-Disciplinary Unit in Southern Africa9
PO91 A LIQUID BIOMARKER REFLECTING PROLIFERATION RATE - THYMIDINE KINASE ACTIVITY - PROVIDES UNIQUE GUIDANCE FOR PREDICTING THERAPY EFFICACY AND MONITORING OF ADVANCED BREAST CANCER9
Eligibility for bilateral prophylactic mastectomy: An expert opinion study in the Netherlands8
Age-stratified toxicity patterns of CDK4/6 inhibitors in older women with breast cancer: Disproportionality analysis from the FAERS database8
Neoadjuvant chemotherapy for radiation associated angiosarcoma (RAAS) of the breast: A retrospective single center study8
P476: Evaluation of Short-Term Postoperative Pain in Breast Surgery Patients using Regional Technique as an Adjuvant8
P380: Rates of Skin and Nipple Necrosis with Inframammary Fold Approach in Nipple-Sparing Mastectomy: A 5-Year Retrospective Single-Center Study8
P098: Role of Contrast-Enhanced Mammography in Breast Cancer: Current Status and Future Directions8
P074: Epithelial-Mesenchymal Transition Markers Expression in Male Breast Cancer8
P208: Use of MammaTyperin predicting response to neoadjuvant therapy in HER2-positive breast cancer8
Development and validation of prognostic model based on distribution and density of CD3+ and CD8+ infiltrating lymphocytes in breast cancer: A multicenter cohort study8
Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBC8
Outcomes, indications and predictive factors for complications in postmastectomy prepectoral reconstructions with polyurethane foam-coated implants8
Trends in local, regional and contralateral breast tumor recurrence within five years after diagnosis in the Netherlands: a population-based study including 121347 patients8
Is preoperative imaging of sentinel lymph node in breast cancer necessary? A retrospective case control study8
P451: Participation of a breast cancer patient in the multidisciplinary team - from decision making to changing the treatment option8
P320: Malignant phyllodes tumor of the breast- experience from a tertiary care center8
P156: The Relevance of Rising Breast Cancer Incidence Among Young Women Under 45 in Ukraine: Challenges in Oncofertility8
P012: 5-year vs 10-year Hormone Therapy: Comparison of Recurrence in Patients with Luminal A and Luminal B Breast Cancer8
Breast RT microcalcifications: a stress test for trainee-led magnetic-seed lumpectomy8
Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy8
Multimodal data integration in early-stage breast cancer8
Survival feature and trend of female breast cancer: A comprehensive review of survival analysis from cancer registration data8
P370: The Alexisretractor in axillary surgery for breast cancer: a preliminary study on reducing surgical complications and enhancing surgical efficiency8
P281: India’s exploration of next-generation sequencing: proteomics based prognostic signature redefining the risk groups in HR +/HER2-negative breast cancer and comparative analysis with grade, Ki67 8
P250: Investigation of Circulating miR-182-3p, miR-382-3p and miR-93, miR -142-3p Involved in Tamoxifen Resistance and Sensitivity in Luminal-Subtype Breast Cancer Patients: A Case-Control Study8
P089: MammaTyper test as a predictive biomarker of neoadjuvant chemo-immunotherapy response in patients with estrogen receptor (ER) low HER2 negative breast cancer8
P415: Sleep quality and influencing factors among tunisian breast cancer patients8
Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer8
“Alas … my sickness becomes my family's burden”: A nested qualitative study on the experience of advanced breast cancer patients across the disease trajectory in Indonesia8
P167 Prediction of Axillary lymph node metastasis by Tumor to breast ratio in breast cancer7
IN1 THE SPARK THAT LIT THE FIRE - LILLIE’S JOURNEYS WITH ABC PATIENTS AND THEIR FAMILIES7
P368: De-escalation of axilla based on ultrasound, is the clinic ready?7
The early Monash experience with targeted axillary dissection: lessons, pitfalls and practice patterns7
Contralateral Breast Cancer: Influence Of Molecular Subtype, Clinical Features And Treatment Given In A Single Institution Study7
Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/pertuzumab for HER2-positive breast cancer7
Clinical significance of serum estradiol monitoring in women receiving adjuvant aromatase inhibitor for hormone receptor-positive early breast cancer7
SA 10.3 Breast cancer treatment and research from an African perspective7
P353: Lymphedema after mastectomy and immediate breast reconstruction – a comparison between patients with and without breast reconstruction in a prospective study7
PO84 LESSONS LEARNED IN DEVELOPING A TREATMENT ACCESS PROGRAM FOR ADVANCED BREAST CANCER IN LOW- AND MIDDLE-INCOME COUNTRIES7
P119 Recurrence Score® result by the 21-gene assay before and after systemic neoadjuvant chemotherapy in patients with HR+ HER2-breast cancer.7
P049 Investigating the pathogenesis of poor-outcome Triple-Negative Breast Cancer7
Corrigendum to ‘Raising awareness of alcohol as a modifiable risk factor for breast cancer: A randomized controlled trial comparing the efficacy of accessing an interactive website with a non-interact7
PO69 CAPTURING LIFE IN COLOR: DOCUMENTING THE LIVED EXPERIENCES OF ADVANCED BREAST CANCER PATIENTS7
P230 Breast reconstruction: recurrence in patients with mastectomy and immediate breast reconstruction7
P238 Is BCT safer than Mastectomy for the treatment of early breast cancer?7
P155 Exploration of specific population for adjuvant capecitabine escalation therapy in early-stage triple-negative breast cancer: a retrospective biological sample analysis of the CBCSG010 clinical t7
Long-term outcomes and effects of hypofractionated radiotherapy in microinvasive breast cancer: Analysis from a randomized trial7
PO82 PERSPECTIVES OF FEMALE HIGH SCHOOL STUDENTS IN GHANA, NAMIBIA, MALAWI AND ZAMBIA: HOW LACK OF ACCESS TO HOLISTIC CANCER CARE FUELS ADVANCED BREAST CANCER IN AFRICA7
Mondor's disease of the breast: A cutaneous thromboembolic manifestation of Covid-19?7
P037: Androgen Receptor Expression and Clinicopathological Features in Triple Negative Breast Cancer6
P033: Targeting Cell Death in MCF-7 Breast Cancer Cells with Green Synthesized Silver Nanoparticles6
Improving the quality of life of people with advanced breast cancer: a global expert review and call-to-action for 2025–2035 (goal 3)6
0.10872292518616